Skyrizi
NDC 0074-8350, risankizumab-rzaa, injection, from AbbVie Inc..
- Product NDC
- 0074-8350
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761105
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-8350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISANKIZUMAB180 mg/1.2mL
Pharmacologic classes
Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-8350-01 | 00074835001 | 2 SYRINGE in 1 CARTON (0074-8350-01) / 1.2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7148c8eb-b39e-e20a-6494-a6df82392858
Use it
Look up 0074-8350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-8350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-8350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.